Ahead of Investor Day, Simply Wall St’s discounted-cash-flow estimate for Marvell Technology stood at roughly $280.25 per share. In its updated projections following the event, SWS raised its estimated fair value to about $541.50 — nearly twice the pre-event level. That shift followed a major change in what Marvell itself says the business could become.
At Investor Day, management raised its fiscal 2028 revenue outlook to approximately $20 billion and laid out a fiscal 2031 revenue opportunity of $70 billion to $90 billion. Reuters reported that even the midpoint of that range stood substantially above expectations that prevailed before the event.
The latest consensus data now show an average 12-month analyst target of roughly $338, up from about $291 previously, with 44 analysts represented in the current consensus.
Management raised the long-term ceiling. Analysts raised their targets. Valuation models then began capitalizing much more of that future success into today’s fair value. For shareholders, that creates opportunity — but also an increasingly asymmetric risk if execution begins to fall short.
Marvell now has much more to prove
There is little question that the underlying operating momentum is strong. Marvell reported fiscal second-quarter revenue of $2.74 billion, up 37% year over year, as AI infrastructure spending continued to drive demand across custom silicon, networking and data-center connectivity.
But the valuation debate has moved far beyond whether Marvell is benefiting from AI. Investors are increasingly being asked to value the company as if a meaningful portion of its enormous 2031 opportunity will actually be converted into revenue and free cash flow. That is a very different proposition.
At current scale, Marvell is still generating annualized revenue of roughly $11 billion. Reaching $70–90 billion by 2031 would require the company to become several times larger within five years. That can happen, but once investors begin paying today for cash flows expected five years from now, the penalty for delays, lost programs, margin pressure or weaker AI capital spending becomes much larger.
The SBC burden makes the valuation particularly sensitive
One risk that deserves more attention is Marvell’s heavy use of stock-based compensation. The company recorded $326.2 million of SBC in the quarter ended August 1, compared with $153.6 million a year earlier. For the first six months of the fiscal year, SBC reached $533.8 million, versus $295.7 million in the comparable prior-year period. Quarterly SBC was therefore roughly 12% of revenue.
Stock-based compensation may not require an immediate cash payment, but shareholders ultimately pay through dilution, and the effectiveness of equity compensation is closely linked to the share price.
When a stock trades at a high valuation, a company needs fewer shares to award employees a given dollar amount of compensation. If the stock falls sharply, delivering the same compensation value requires more shares, increasing dilution or greater use of cash compensation. That creates an uncomfortable feedback loop.
A high Marvell share price helps make its substantial equity-compensation program easier to absorb. But maintaining that elevated share price increasingly depends on investors believing that management’s extraordinary AI growth targets remain achievable. If those expectations weaken, the company could face both a valuation reset and a less favorable dilution equation at the same time.
This is where the valuation gap matters
Our investigation produces a very different result when Marvell is valued using a conservative capital-preservation framework. Rather than assuming that the current AI growth cycle persists deep into the forecast period, the approach explicitly charges shareholders for Marvell’s unusually heavy SBC burden and gradually fades exceptional near-term growth toward a 3% terminal rate over an eight-year forecast period.
That framework produces a current midpoint fair value of approximately $56.81 per share.
The purpose of the estimate is not to suggest that Marvell must immediately fall to $57. It demonstrates something more important: how much of the current valuation depends on future execution rather than financial performance already visible in the accounts.
The AI race may be entering its most dangerous phase
Marvell’s Investor Day strengthened the fundamental bull case. The company has positioned itself squarely in some of the fastest-growing portions of AI infrastructure, and management now sees a path toward a dramatically larger enterprise.
The debate is no longer simply whether Marvell can win in AI. The question is how much of that victory has already been priced into the shares.
When management forecasts, analyst targets and aggressive DCF valuations begin converging around highly successful long-term outcomes, the margin for disappointment contracts. For investors arriving after the upgrades, that may be the most important signal of all.
The danger is no longer missing the AI race. It is paying today as though the race has already been won.
Sources:
https://stockanalysis.com/stocks/mrvl/transcripts/724088-inv
https://stockanalysis.com/stocks/mrvl/forecast/
https://simplywall.st/stocks/us/semiconductors/nasdaq-mrvl/